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Abstract  
Background/Aims: (1) To investigate how specific executive functions change over 
2 years in drivers with Parkinson’s Disease (PD) compared to controls, using both 
neuropsychological and driving simulator tasks; and (2) to explore the association 
between the decline of specific executive functions and changes in driving habits in 
PD.  
Methods: Sixteen PD patients and 21 controls twice underwent neuropsychological 
testing and performed tasks on a driving simulator, at a distance of approximately 2 
years. Questions on participants’ self-perception of their driving ability were 
administered. 
 Results: A significant decline was observed in shift cost over time (Plus minus test) 
in patients (p = 0.008). This decline was greater in patients than in controls (p = 
0.008). No significant change emerged over time in the flexibility cost of PD patients 
on a simulator (p = 0.158). Significant correlations were found between the decline in 
shift cost over time and driving question outcomes (p < 0.05).  
Conclusion: This study reveals a differential course of executive functions in PD. 
Over time, patients displayed a significant decline in flexibility, associated with 
modifications in their driving. Flexibility seems to be affected later than updating in 
the disease. This research opens new avenues in cognitive and driving rehabilitation.  
Word count: 200 
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Introduction 
Parkinson’s disease (PD) is a progressive neurodegenerative disorder which 
affects the instrumental activities of daily living, including the ability to drive a car [1-
5]. The number of individuals with PD is expected to grow substantially over the next 
20 years [6], posing challenges for health care professionals and driving rehabilitation 
specialists who determine fitness-to-drive. 
Although the best-known deficits in PD are motor in nature, non-motor 
cognitive deficits may also appear, even in the early stages [7]. The most frequently-
reported of these early-stage cognitive deficits occur in the domains of executive 
function and memory [7].  
While cross-sectional studies of patients at various stages of PD show 
cognitive changes  [7, 8], few longitudinal studies have examined changes in 
cognitive function in PD [9, 10]. Discrete cognitive decline  has been shown to  occur  
in PD, even over short-periods [9, 11]. Muslimovic et al. [11] showed that in  newly-
diagnosed  PD patients, cognitive performance subsequently decreased over three 
years. The most severe deficit after three years affected measures of psychomotor 
speed and attention. Although deterioration in memory, visuospatial skills and 
executive function was of lesser magnitude, it was nevertheless more pronounced 
than in healthy controls. Findings from a previous study showed that executive 
function tasks proved most sensitive to disease progression [9].  
Executive functions are paramount in most instrumental activities of daily 
living, including the ability to drive a car. In two recent studies, we showed the impact 
of specific executive functions on driving in individuals with PD [2, 4]. To date, only 
one prospective follow-up study has investigated driving abilities and crash risk in 
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individuals with PD [12]. This research showed that 2 years after baseline, the risk of 
driving cessation was higher in PD drivers than in controls. Cognitive and visual 
impairments and severity of parkinsonism were associated with driving cessation in 
the PD group.  
To our knowledge, no study has investigated the decline of specific executive 
functions over time in individuals with PD who continue to drive. Previously, we 
described the demographic, clinical and driving characteristics of 25 individuals with 
mild-to-moderate PD and 25 controls who were active drivers [4]. Our experimental 
approach consisted of isolating executive functions in a driving context. Participants 
performed an executive task while driving a simulator. Baseline findings (t0) revealed 
an updating impairment in drivers with PD in both neuropsychological tests and the 
simulator task. We now present the 2-year follow-up (t2) in individuals with PD and 
controls who are still active drivers.  
The aims of this study were (1) to investigate how specific executive functions 
change over 2 years in individuals with PD compared to controls and (2) to explore 
the associations between the decline of specific executive functions and changes in 
driving in individuals with PD.  
Materials and Methods 
Participants 
At the initial session (t0), 25 individuals with PD (mean age: 65.4 ± 5.2) and 25 
healthy controls (mean age: 66.7 ± 4.4) matched for sex, age, education level and 
driving experience were included [4]. At the second session (two years later, t2), 16 
of the 25 individuals with PD were reassessed after an average follow-up of 821 ± 
92.89 days (Table 1). Five individuals with PD refused retesting, 3 stopped driving 
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and one could not be retested due to dementia or severe confusion. Twenty-one of 
the 25 controls were reassessed after an average follow-up of 779 ± 61.37 days. 
Four controls refused retesting. No significant differences in demographic and clinical 
variables appeared at t0 between the individuals with PD who declined retesting and 
those who agreed to participate in the second session (p>0.05). Similar results were 
found in controls. The average follow-up period for patients was not significantly 
different from the follow-up period of controls.  
Disease progression was significantly more advanced in PD patients at t2 than at t0 
(Hoehn and Yahr score: 1.75 ± 0.32 at t0 versus 2.22 ± 0.41 at t2, p = 0.002).  Daily 
levodopa dosages were significantly higher in PD patients at t2 than at t0 (Levodopa 
dosage (mg): 270.31 ± 223.46 at t0 versus 464.29 ± 441.66 at t2, p = 0.002).  
Fourteen individuals with PD were treated with levodopa. Nine individuals with PD 
were taking dopamine agonists (pramipexole, ropinirole, piribedil), 3 were on COMT 
inhibitors (entacapone), and 5 on MAO inhibitors (selegiline, rasagiline). One patient 
was medication-free.   
Inclusion criteria  
Inclusion criteria for patients were as follows: mild-to-moderate-stage PD; idiopathic 
PD in accordance with the United Kingdom’s Parkinson’s Disease Brain Bank criteria 
[13]; older people with no neurological disease (control group); current regular drivers 
using a car with a manual gearbox. 
Exclusion criteria  
Exclusion criteria included: cessation of driving; global cognitive deterioration, based 
on a score of 24 or less in the Mini Mental State Examination (MMSE); moderate-to-
severe depression based on a clinical interview and a score of 17 or more in the 
6 
 
Beck Depression Inventory; far visual acuity inferior to 6/10; presence of neurological 
disorders other than idiopathic PD. 
The study was approved by the local biomedical ethics committee. Informed written 
consent was obtained from all subjects following the Helsinki guidelines. 
Neuropsychological assessment 
The same methodology was used at t0 and t2 (for more details, see explanations in 
Ranchet et al. [4]). Psychomotor speed was measured using part A of the TMT. 
Global executive function was assessed by the Trail Making Test (TMT B-A) and 
individual executive functions such as mental flexibility, updating and inhibition were  
assessed by the Plus Minus Task (PMT) (shift cost), n-back task (Response times in 
2-back condition),  and Stroop test (inhibition cost), respectively.  
Driving simulator and experimental tasks 
The experiment was conducted using a fixed-base simulator, a Renault Espace 
car with a manual gearbox and hidden instrumentation and sensors. The vehicle 
has a three-screen front view with a horizontal visual field of 150 degrees and a 
vertical visual field of 40 degrees. Participants familiarized themselves with 
simulated driving for 20 minutes. The tasks were performed by using in-house 
software developed at IFSTTAR. The refresh rate was 30 Hz. In the updating task, 
the main task was to recall the three last-seen road signs while driving. In the 
flexibility task, participants were instructed to switch between two tasks and 
indicate the colour of the road sign when it was placed on the left-hand side or its 
shape when it was placed on the right-hand side [for a detailed description, see 4]. 
In both tasks, participants were asked to drive at a constant speed of 90 km/h in 
7 
 
both tasks. Task performances during simulated driving, mean speed and speed 
variability (mean SD of speed) were measured. 
Questions on self-perception of subjects’ driving ability 
Participants replied to 3 questions about their habits and difficulties while driving. 
The first question was asked at t0 and t2 and the last two were asked only at t2. 
Question 1 was: “How do you judge your driving skills?” with self-evaluation 
ranging from 0 to 10. Questions 2 and 3 were adapted from a commonly-used 
questionnaire [14]. Question 2 was: “Which driving situations are more difficult 
than two years ago?”  Participants had to indicate which situations from the 17 
propositions (e.g. highway driving, night driving) they found more difficult. The total 
number of difficult situations represented the difficulty score (/17). Question 3 was: 
“Which driving situations do you avoid?” The same situations as in Question 2 
were proposed. The total number of avoided situations represented the avoidance 
score (/17).  
Procedure 
Neuropsychological tests and tasks on the driving simulator were performed at the 
French institute of science and technology for transport, development and network 
(IFSTTAR) in France at t0 and t2. Each session lasted 3 hours. All patients were 
tested during “on” medication periods. The same neuropsychological tests and 
driving simulator tasks were administered at t0 and t2. The same investigator (MR) 
assessed all participants at both sessions. 
Statistical analysis 
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Variables were assessed for normality using Shapiro-Wilk tests. Differences across 
time were examined using two-tailed Wilcoxon Ranked Sums tests to investigate the 
change over time in both groups [9]. Change scores were calculated as the score at 
follow-up (t2) minus the score at baseline (t0) in order to explore the extent to which a  
function declined over time [15]. Differences between patients and controls at 
baseline (t0), at follow-up (t2) and change scores were analyzed with a one-way 
independent sample t test or a U Mann-Whitney test, where appropriate. We used a 
two-tailed t-test, U Mann-Whitney test or Fisher exact test for categorical variables   
on questionnaire data. Spearman correlations between the flexibility change score 
and data from the questionnaire were analyzed in order to investigate whether the 
significant decline over time of specific executive functions was associated with a 
change in driving habits.  A p-value of 0.01 was selected for both within-group and 
between-group comparisons due to the number of tests administered and the small 
sample size in the two groups. P-values < 0.05 were significant for correlation 
analyses. Statistical analysis was carried out using SPSS 17.0. 
Results 
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Neuropsychological performances 
Between-group differences at t0 and t2 
As expected, PD patients had lower MMSE scores than controls at t2. At t2, patients’ 
response times were significantly longer than controls’ response times in inhibition 
cost whereas at t0, no significant differences were observed between the two groups 
(Table 2).  
Within-group differences - Decline over time 
 PD patients’ performance remained stable over time on most tests. However, 
patients were significantly slower than controls when performing part A of the TMT. 
Importantly, shift cost declined significantly over time in patients, suggesting a decline 
in flexibility over time.  
Controls’ response times declined significantly over time in the 2-back condition, 
suggesting a decline in updating over time.  
Change score – Magnitude of decline 
The change score (right column in table 2) was used to assess the magnitude of 
decline in patients and controls. Change scores for part A of the TMT, and change 
scores for inhibition cost were significantly more pronounced in patients than in 
controls. The most relevant findings concerned the change score in shift cost, which 
was more pronounced in PD patients than in controls. Greater variability of 
performance was observed in PD patients than in controls. 
To summarize, findings showed a significant decline in shift cost over time, and this 
was more pronounced in patients than in controls.  
10 
 
Driving simulator performances  
Between-group differences at t0 and t2 
At t2, patients performed significantly more poorly than controls in the updating task 
(Table 3).  
Within-group differences - Decline over time 
 Speed variability in the flexibility task was significantly higher at t2 than at t0 in 
patients. 
Change score – Magnitude of decline 
The average change score for flexibility cost was more pronounced in patients than in 
controls. However, the difference between the two groups did not reach statistical 
significance. 
The two main findings reveal a significant deficit in patients’ updating score on the 
simulator at t2, and a significant decline over time in their speed variability in the 
flexibility task on the simulator.  
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Questions on driving ability and self-perception 
Question 1 
At t0, there was no difference between patients’ and controls’ judgment of their own 
driving competency. However, at t2, a significant difference concerning driving 
competence appeared between PD patients and controls (Table 4). Controls judged 
themselves significantly better at t2 than at t0. 
 
Question 2  
 
 At t2, PD patients reported a greater number of difficult driving situations (from the 
17 propositions) than controls, (npatients=3.94±3.21 vs ncontrols=1.62±1.53, U=242, 
p=0.023). 
Question 3 
Patients also reported avoiding more driving situations than controls 
(npatients=5.06±2.91 vs ncontrols=1.76±1.55, U=284.5, p<0.001).  
Correlations between the change score of shift cost (PMT) and driving question 
scores in PD patients  
Results showed a significant correlation between the change score of shift cost and 
the number of difficult driving situations at t2 (rho=0.527, p=0.043), and a significant 
correlation between the change score of shift cost and the number of avoided 
situations at t2 (rho=0.543, p=0.036). 
In summary, patients reported a higher number of difficult driving situations, and 
avoidance of more driving situations than controls. 
Discussion  
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Our findings show that in PD, cognitive decline is relatively slow over two 
years [9, 11, 16]. The decline over time occurs mainly on measures of psychomotor 
speed (TMT-part A), and this is consistent with previous results [11]. We will now 
discuss the main findings from our neuropsychological tests, driving simulator results 
and responses to driving questions. 
Neuropsychological tests show flexibility decline in PD  
We showed a significant decline in our PD patients’ flexibility function over two 
years. The decline over time was significantly greater in PD drivers than in controls. 
Although findings from cross-sectional studies show a flexibility deficit in PD patients 
[17, 18], the decline in mental flexibility over two years of PD has not yet been 
specifically investigated. By contrast, we found no significant decline in mental 
flexibility over time in controls. It is possible that in normal ageing, the flexibility deficit 
appears later [19, 20]. The present research suggests that the decline of mental 
flexibility over time is more sensitive to PD progression than to the progression of 
normal ageing. 
While we did not find a significant decline over time for the updating function in 
drivers with PD in the 2 back condition, we did observe an updating deficit at t0 in the 
whole sample (n=25) [4].  At t2, no significant updating deficit was observed in 
patients compared to controls. Several explanations can be put forward to explain 
this absence of difference. Firstly, a deficit in the updating function might occur earlier 
in the progression of PD. Secondly, cognitive impairment may have been more 
severe in the patients who gave up. As the remaining patients were healthier, the 
difference between patients and controls with preserved global cognitive abilities 
(mean MMSE score at t2 = 29) was not significant. Thirdly, the updating deficit in 
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older adults may also be related to healthy age-related decline. This is consistent 
with studies that show an updating deficit in healthy older individuals whose average 
age is 70 [19, 21, 22].  
Driving simulator tasks reveal a decrease in flexibility task performance 
Contrary to our observations in the neuropsychological tests, we did not see any 
significant decline over time in flexibility cost during driving in individuals with PD. 
However, a significant decline over time in speed variability was observed in patients 
during the flexibility task, and suggests poorer driving performances at t2 than at t0. It 
is possible that the drivers with PD allocated attentional resources to the flexibility 
task instead of maintaining a stable driving speed. Previous studies have shown that 
people with PD have difficulty completing two tasks simultaneously [23]. Findings at 
t2 also showed that drivers with PD had poorer performances in the updating task 
than controls. This result was not observed in the n-back task. The appearance of the 
updating deficit during simulator driving may be due to an increase in cognitive 
demand.  
PD patients have appropriate self-perception of their driving ability   
A large proportion of individuals with PD self-regulated their driving habits over two 
years, reducing the number of miles driven per year. At t2, they reported a greater 
number of difficult situations and avoided more driving situations than controls. These 
results are in accordance with those described in the literature [24, 25]. At t0, we did 
not find a significant difference between the two groups’ self-assessment of their 
driving skills. Nor did we show a significant change in their self-assessment of driving 
skills over a two-year disease-period. Cognitive decline may be too discrete to 
interfere with self-perception of their driving abilities. While patients’ perception of 
their driving skills remained stable over two years of progression, we observed that 
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controls judged themselves significantly better at t2 than t0. This perceived 
improvement may stem from a time-related decline in controls’ self-evaluation ability. 
This finding could be related to a decline over time in controls’ perception of their 
driving skills. Older controls had difficulty estimating their driving abilities accurately 
[26]. Future studies on a larger-sized sample should explore changes perceived over 
time in patients and controls.  
Significant correlations between the change score in shift cost and driving question 
outcomes suggest that the decline in flexibility over two years of PD was associated 
with a change in patients’ driving habits. We assume that the decline in flexibility over 
two years of PD may already affect driving. Previous cross-sectional studies have 
shown that flexibility may impact driving performance [2, 27]. Further research should 
continue to explore the effect of cognitive tasks on driving performance in the real 
world.   
Limitations of the study 
The small sample size limits the use of statistical methods applied to longitudinal 
studies [16]. We cannot therefore generalize these findings to the general PD 
population. The absence of significant changes between the two assessments could 
be due to the fact that heterogeneity in the progression of PD is greater than that of 
normal ageing [16, 28]. The fact that performances during simulated driving remained 
relatively stable or improved could reflect practice effects. It has been demonstrated 
that performance of relatively difficult or novel tasks tends to improve due to 
increased familiarity with the procedures [29]. Other driving measures sensitive to 
vehicle control such as lane position and variation of lane position should be further 
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explored. The use of driving simulators in longitudinal studies needs to be further 
explored. 
 A limitation is the small sample size that limits the use of statistical methods applied 
to longitudinal studies and the generalization to the PD population. The lack of 
significant changes over time could be due to a greater heterogeneity in the 
progression of PD.14 Performances on the driving simulator remained relatively stable 
or improved, which could reflect practice effects. The use of driving simulators in 
longitudinal studies needs to be further explored.  
 
 
Perspectives 
This study’s findings may have implications for future research in cognitive and 
driving rehabilitation. Targeted training of specific executive functions could prove to 
be a key component in cognitive rehabilitation interventions aimed at improving  
driving abilities and driving-related cognitive functions in patients with PD [30]. In the 
early stages of PD, training of the updating function may be more beneficial than 
specific training of the flexibility function. However, later in the disease, specific 
training of the flexibility function might improve driving abilities and cognitive 
functions. Further research should explore the potential of a non-contextual training 
program to improve cognitive functions and mobility in patients with PD.  
 
Conclusion 
This research showed a differential course of executive functions across PD, leading 
to modifications in driving habits. Updating information in the working memory 
appears to be affected earlier in the disease than flexibility [4]. Decline in flexibility 
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appears to be more pronounced in patients than in controls, suggesting that, over 
two years of progression, flexibility is more sensitive to PD than to normal ageing.  
Further longitudinal studies investigating the decline in cognitive functions over time 
in drivers with PD should be considered. 
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Table 1. Demographic and clinical characteristics of PD patients and controls at t2  
  
PD group Control group   
n = 16 n = 21 p-value* 
mean (SD) mean (SD) two-tailed 
Age (years) 67.8 (4.8) 69.1 (3.9) 0.380 
Sex, n men (%) 12 (75)  17 (81.0) 0.705 
Years of education 13.5 (3.3) 13.6 (2.7) 0.938 
Years of driving 43.4 (5.1) 45.1 (6.0) 0.348 
Mileage driven per year
a
, n 6/3/6/1   0/4/16/1 0.006 
     
BDI score 21 items  
9.6 (4.7) 5.3 (3.0) 0.009 
ESS score (max. score: 24) 9.1 (2.8) 6.0 (3.3) 0.01 
Hoehn and Yahr stage (range: 0-5) 2.2 (0.4)  -  
Disease duration (years)  6.9 (4.3) -  
Disease onset age (years) 60.8 (7.1) -  
UPDRS - motor score (max.score: 108) 17.0 (4.4) -  
Levodopa dosage (mg/day)
b
 464.3 (141.7)  -  
Values in bold are significant. 
Abbreviations: BDI: Beck Depression Inventory; ESS: Epworth Sleepiness Scale; UPDRS: Unified 
Parkinson Disease Rating Scale 
* P-value < 0.05 
a 
Less than 3000 km/ between 3500 and 7000 km/ between 7000 and 20000 km/ more than 20000 km 
b
 Levodopa (+dopa-decarboxylase inhibitor) without dopaminergic agonists 
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Table 2. Baseline, follow-up, and change scores in neuropsychological tests for PD 
patients and elderly controls.  
   t0 t2   Change score
c
 
 
n Group mean (SD) mean (SD) 
p-
value
a 
 
 mean SD) 
Global cognitive assessment              
     MMSE 16  patients  28.1 (1.2) 27.6 (1.5) 0.286 
 
 -0.5 (1.6) 
 
21 controls 29.2 (0.8) 29.3 (0.7) 0.564  0.05 (0.8) 
p-value
b
 
  
0.002 0.001 
 
 0.083 
     Trail Making Test (TMT)        
Part A times (s) (1) 15 patients 41.8 (10.8) 50.8 (13.1)  0.007  9.0 (10.4) 
 
21 controls 44.3 (16.8) 39.1 (15.4) 0.217   -5.2 (18.8) 
p-value 
  
0.455 0.010 
 
 0.008 
Part B times (s) (2) 15 patients 79.3 (36.2) 113.5 (83.9)  0.041  34.3 (58.3) 
 
21 controls 75.4 (27.8) 75.5 (25.5) 0.852  0.1 (22.8) 
   
0.424 0.121 
 
 0.048 
TMT (B – A) (2) - (1) 15 patients 37.5 (29.4) 62.7 (76.9) 0.348  25.3 (58.8) 
 
21 controls 31.1 (19.6) 36.4 (21.5) 0.348  5.3 (24.5) 
p-value 
  
0.392 0.424 
 
 0.418 
     Stroop test - inhibition cost (s)
d
 14 patients 63.4 (30.5) 85.6 (61.2)  0.014  22.1 (47.2) 
 
21 controls 53.5 (19.4) 53.9 (16.3) 0.602  0.4 (12.9) 
p-value 
  
0.209 0.007 
 
 0.009 
Updating  
 
  
 
  
 
 
     n-back task        
2-back  
  
 
  
 
 
Response times (ms) 16 patients 712.1 (158.9) 765.7 (197.8) 0.281  53.7 (184.1) 
 
21 controls 633.1 (144.7) 705.8 (114.4) 0.006  72.7 (99.8) 
p-value 
  
0.122 0.145 
 
 0.345 
Errors 16 patients 2.8 (2.4) 4.4 (3.5) 0.083  1.7 (3.1) 
 
21 controls 1.5 (2.3) 2.1 (2.9) 0.240  0.7 (2.4) 
p-value     0.009 0.018    0.135 
Flexibility               
Plus Minus task - Shift cost 
(s)
e
 
15 patients 17.8 (13.4) 31.9 (27.8)  0.008  14.2 (21.1) 
 
21 controls 20.4 (12.8) 20.7 (15.7) 0.641  0.3 (15.3) 
p-value     0.255 0.140    0.008 
Information-processing speed               
Stroop test - Color naming                
completion times (s)  
14 patients 64.0. (10.8) 68.1 (14.8) 0.046 
 4.1 (6.7) 
 
21 controls 62.5 (7.4) 64.3 (10.0) 0.303  1.8 (5.9) 
p-value     0.420 0.301    0.18 
Values in bold are significant (p<0.01). 
Abbreviations: MMSE: Mini Mental State Examination; SD:  Standard Deviation; TMT: Trail Making 
Test 
a 
P-value for within-group comparisons (decline over time) 
b 
P-value for between-group comparisons (deficit) 
c 
Change score (magnitude of decline) = score t2 – score t0. Positive values means poorer 
performances at t2. Negative values means better performances at t2. 
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d
 Inhibition cost was calculated as being the difference between mean completion times of the third 
condition and the mean completion times from the first two conditions.  
e
 Shift cost was calculated as being the difference between mean completion times of the third list and 
mean completion times from the first two lists. 
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Table 3.   Baseline, follow-up, and change scores in driving simulator tasks for PD 
patients and elderly controls. 
      t0 t2  Change score
c
 
  n Group mean (SD) mean (SD) p-value
a
 mean (SD) 
Updating task             
   Updating score, n  15 patients 39.5 (7.2) 35.0 (10.4) 0.151  -4.5 (10.3) 
 20 controls 43.0 (4.4) 43.8 (4.5) 0.348 0.8 (4.1) 
   p-value
b
   0.078 0.003  0.051 
   Mean speed (km/h) 15 patients 81.1 (9.6) 85.0 (17.1) 0.256 4.0 (14.8) 
 20 controls 82.9 (6.3) 81.0 (8.76) 0.313  -1.9 (8.7) 
   p-value   0.193 0.408  0.062 
   Speed variability
d
 15 patients 8.6 (3.1) 11.4 (4.9) 0.088 2.8 (5.1) 
 20 controls 9.7 (2.5) 9.5 (2.3) 0.911  -0.2 (3.1) 
   p-value     0.103 0.222   0.033 
Flexibiity task       
   Flexibility cost 14 patients 61.8 (556.9) 497.4 (543.0) 0.158 435.6 (970.0) 
 20 controls 138.2 (484.9) 202.4 (336.2) 0.911 64.1 (506.2) 
   p-value     0.472 0.058   0.147 
   Mean speed (km/h) 14 patients 97.4 (18.2) 92.9 (23.7) 0.826  -4.4 (30.6) 
 20 controls 92.3 (4.5) 91.3 (15.5) 0.654  -0.9 (15.7) 
   p-value   0.164 0.242  0.376 
   Speed variability 14 patients 4.3 (1.9) 11.7 (9.8) 0.006 7.4 (9.9) 
 20 controls 4.6 (2.2) 9.8 (10.2) 0.191 5.1 (10.3) 
   p-value   0.383 0.071  0.076 
Values in bold are significant (p<0.01). 
a
 P-value for within-group comparisons (differences across time) 
b
 P-value for between-group comparisons  
c 
Change score (magnitude of decline) = score t2 – score t0. Positive values mean poorer 
performances at t2. Negative values mean better performances at t2. 
d
 Mean standard deviation of speed 
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Table 4.  Self-assessment of driving competence in patients and controls (question 1) 
 
 n  t0 t2 p-value
a
 
Mean mark /10 (SD)  16 patients 7.5 (1.3) 7.2 (1.0) 0.451 
21 controls 7.9 (1.1) 8.2 (1.0) 0.039 
p-value
b
   0.147 0.009  
Values in bold are significant 
a 
P-value for within-group comparisons (differences across time) 
b 
P-value for between-group comparisons  
 
 
 
